pharmaceutical investing Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
pharmaceutical investing Keryx Biopharmaceuticals Announces Publication of Data from the Phase 3 Trial of Auryxia